Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spreading Vasoconstriction in Human Gingiva
NCT04131283Completed
- Sponsor
- Semmelweis University
- Start
- May 2019
- Primary completion
- Dec 2019
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Open-label trial of epinephrine in vasoconstriction (2 arms), sponsored by Semmelweis University. Primary endpoint: Blood flow change after application of epinephrine at 30 minutes. Started May 2019; status: completed.
02
Drugs
epinephrine
03
Conditions
vasoconstriction
Beyond the preview
Go deeper on NCT04131283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04131283.